Latest Commercialization News

Liberty Group has reported a solid 16% rise in statutory net profit after tax for FY25, alongside a 10% increase in underlying earnings and a new special dividend announcement.

IPD Group Limited has delivered record financial results for FY25, hitting the top end of its guidance with robust revenue growth and a significant dividend increase. The company’s strategic acquisitions and expansion into key infrastructure sectors underpin its optimistic outlook.

IPD Group has reported record full-year results for FY25, with revenue surging 22.1% to $354.7 million and net profit rising 17% to $26.2 million. The company’s growth is underpinned by strategic acquisitions and strong demand in data centres and EV infrastructure.

IPD Group Limited has reported record revenue and profit for the year ended 30 June 2025, driven by growth in key infrastructure sectors despite commercial construction headwinds. The company also declared a fully franked final dividend and significantly reduced its debt.

Ansell Limited reported record FY25 sales and EBIT margins, completing KBU integration ahead of schedule and upgrading synergy targets. The company guides higher adjusted EPS for FY26, fully offsetting US tariff hikes through pricing.

Tourism Holdings Limited reported a statutory net loss in FY25 amid challenging market conditions but remains confident in a strategic turnaround targeting over $100 million in annualised NPAT within four years.

INOVIQ Limited reported a $6.9 million net loss for FY25 while making significant strides in its exosome-based cancer diagnostics and therapeutics pipeline, including a breakthrough ovarian cancer screening test and promising CAR-exosome therapy results.

Peninsula Energy outlines a revised production roadmap for its Lance uranium project in Wyoming, addressing commissioning delays and legacy contract burdens while securing fresh capital to fuel growth amid strong US nuclear energy momentum.

RLF AgTech Ltd has secured $4.5 million through a discounted share placement to support its strategic growth initiatives following a robust 74% revenue increase in FY2025. The company is advancing its Australian relaunch, expanding manufacturing, and entering new Asian markets.

NOVONIX Limited reports progress scaling its Chattanooga synthetic graphite plant, secures major funding, and benefits from U.S. tariffs on Chinese imports, while narrowing its half-year loss.

LTR Pharma has announced that its erectile dysfunction treatment SPONTAN now boasts an 18-month shelf life, surpassing commercial standards and paving the way for international market growth.

BCI Minerals has transitioned to full-scale operations at its Mardie Salt Project, marking a pivotal moment with strong construction progress, secured financing, and binding offtake agreements. The company remains on track for first salt shipment by late 2026.